These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9823452)

  • 21. [Bone histology after intermittent PTH treatment - animal models -].
    Sasaki M; Hasegawa T; Hongo H; Yamamoto T; Amizuka N
    Clin Calcium; 2013 Mar; 23(3):347-53. PubMed ID: 23445886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women.
    Drake MT; Srinivasan B; Mödder UI; Ng AC; Undale AH; Roforth MM; Peterson JM; McCready LK; Riggs BL; Khosla S
    Bone; 2011 Sep; 49(3):349-55. PubMed ID: 21600325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transactivation of core binding factor alpha1 as a basic mechanism to trigger parathyroid hormone-induced osteogenesis.
    Fujita T; Fukuyama R; Izumo N; Hirai T; Meguro T; Nakamuta H; Koida M
    Jpn J Pharmacol; 2001 Aug; 86(4):405-16. PubMed ID: 11569614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
    Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
    Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of signal-selective parathyroid hormone analogue peptide on expressions of Wnt signaling factors].
    Feng R; Jiang J; Li J; Fu Z; Lin Z; Yuan L; Yang D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Apr; 26(4):472-6. PubMed ID: 22568332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone potentiates the effect of insulin-like growth factor-I on bone formation.
    Spencer EM; Si EC; Liu CC; Howard GA
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):435-42. PubMed ID: 2800920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats.
    Miller SC; Hunziker J; Mecham M; Wronski TJ
    J Dent Res; 1997 Aug; 76(8):1471-6. PubMed ID: 9240383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I.
    Kostenuik PJ; Harris J; Halloran BP; Turner RT; Morey-Holton ER; Bikle DD
    J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats.
    Onyia JE; Bidwell J; Herring J; Hulman J; Hock JM
    Bone; 1995 Nov; 17(5):479-84. PubMed ID: 8579960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling.
    Krishnan V; Moore TL; Ma YL; Helvering LM; Frolik CA; Valasek KM; Ducy P; Geiser AG
    Mol Endocrinol; 2003 Mar; 17(3):423-35. PubMed ID: 12554794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
    Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
    J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.
    Soma S; Matsumoto S; Takano-Yamamoto T
    Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell analysis of cyclic AMP response to parathyroid hormone in osteoblastic cells.
    Civitelli R; Bacskai BJ; Mahaut-Smith MP; Adams SR; Avioli LV; Tsien RY
    J Bone Miner Res; 1994 Sep; 9(9):1407-17. PubMed ID: 7817824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
    Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
    J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I; Keller H; Leupin O; Kneissel M
    Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats.
    Ominsky MS; Brown DL; Van G; Cordover D; Pacheco E; Frazier E; Cherepow L; Higgins-Garn M; Aguirre JI; Wronski TJ; Stolina M; Zhou L; Pyrah I; Boyce RW
    Bone; 2015 Dec; 81():380-391. PubMed ID: 26261096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.
    Idris AI; Greig IR; Bassonga-Landao E; Ralston SH; van 't Hof RJ
    Endocrinology; 2009 Jan; 150(1):5-13. PubMed ID: 18772231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
    van der Horst G; Farih-Sips H; Löwik CW; Karperien M
    J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.